Gapping up
In reaction to strong earnings/guidance:
- BOOT +16.1%, M +11.1%, MFGP +8.9%, SE +6.2%, ODP +2.6%, PETQ +0.9%
M&A news:
- ABAX +14.9% (to be acquired by Zoetis (ZTS) for $83/share in cash)
Select metals/mining stocks trading higher:
- RIO +2.4%, BBL +1.4%, BHP +1.4%, VALE +0.8%
Other news:
- GME +9.2% (CNBC reporting that Tiger Management has issued a letter urging the company to launch a strategic review)
- SGMO +4% (FDA has accepted the Investigational New Drug (IND) application for BIVV003 for the treatment of people with sickle cell disease)
- TEVA +3.6% (Berkshire Hathaway (Warren Buffett) discloses updated portfolio positions - increased stake)
- ADMA +3% (United States Patent and Trademark Office issued to the Company U.S. Patent No. 9,969,793 covering methods of treating respiratory infections), EIGR +2.7% (expands licensing agreement with Merck)
- MU +2% (continued strength)
- XNET +1.4% (continued strength)
- CHDN +1.3% (announces entry into real money online gaming and sports betting markets)
- SNY +0.6% (Regeneron Pharma (REGN +0.5%) & Sanofi announce that a pivotal Phase 3 trial evaluating DUPIXENT to treat moderate-to-severe atopic dermatitis in adolescents met its primary and key secondary endpoints)
Analyst comments:
- AMD +1.4% (upgraded to Neutral from Negative at Susquehanna)